Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid... see more

OTCPK:TRPXY - Post Discussion

View:
Post by easyas123 on Dec 11, 2018 9:08am

Release

Reuters BRIEF-Therapix Biosciences Provides Update Regarding Fsd Acquisition 12/11/2018 8:57:42 AM Therapix Biosciences Ltd: * THERAPIX BIOSCIENCES PROVIDES UPDATE REGARDING FSD ACQUISITION * THERAPIX BIOSCIENCES LTD - IT WAS AGREED THAT TERMS OF LOI ARE TO BE SUPERSEDED BY A DEFINITIVE AGREEMENT * THERAPIX BIOSCIENCES LTD - TRANSACTION IS STILL BEING NEGOTIATED * THERAPIX BIOSCIENCES LTD - COMPANY AND FSD ARE STILL IN NEGOTIATIONS AND FSD WISHES TO MODIFY CERTAIN MATERIAL TERMS OF TRANSACTION Source text for Eikon: Further company coverage: This is not the update we wanted. Maybe this will spark some interest from another party, that would be ideal.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities